Patient Education Sheet Library
Search Results
High-Dose Cytarabine
Cytarabine is used for acute myeloid leukemia (AML).
Treatment Given by InfusionDownloads:
Download (English)Nivolumab and Ifosfamide, Carboplatin, and Etoposide
The combination of nivolumab, ifosfamide, carboplatin, and etoposide is used for Hodgkin lymphoma.
Treatment Given by InfusionDownloads:
Pembrolizumab and Sacituzumab Govitecan
This combination of pembrolizumab and sacituzumab govitecan is used for breast cancer.
Treatment Given by InfusionDownloads:
Bevacizumab and Irinotecan
The combination of bevacizumab and irinotecan is used for colon or rectal (colorectal) cancer (CRC)…
Treatment Given by InfusionDownloads:
Dexamethasone, Etoposide, Ifosfamide, and Carboplatin
The combination of dexamethasone, etoposide, ifosfamide, and carboplatin is used for certain types of lymphoma.
Treatment Given by InfusionDownloads:
Pivekimab Sunirine
Pivekimab sunirine is used for a rare type of blood cancer called blastic plasmacytoid dendritic…
Treatment Given by InfusionDownloads:
Etoposide, Doxorubicin, Cisplatin, and Mitotane
The combination of etoposide, doxorubicin, cisplatin, and mitotane (EDP-M) is used for cancer of the…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin
The combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin (DCEP) is used for multiple myeloma (MM).
Treatment Given by InfusionDownloads:
Mycophenolate
Mycophenolate is used for graft-versus-host disease (GVHD).
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Letermovir
Letermovir is used for the prevention of cytomegalovirus (CMV) infection.
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
